This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Exclusive: Inside Pandora's Music Genome Project, Part One

Stocks in this article: P

NEW YORK (TheStreet) -- There's no doubt I have the greatest job in the world. It's impossible -- and ungrateful -- to complain about anything I do. That said, I like some parts of the gig better than others.

Truth be told, I don't get as much out of, say, the Netflix (NFLX) story, as I used to. Bullish and as prophetic as anybody on the stock, it's cartoonish to continue policing the inanity of the underlying business. I don't want the stress and shame of being part of the cartoon. I'll leave that to Reed Hastings and his choir of press release writers in the media.

I feel better about myself, the material I deliver to readers and the contribution I make to larger conversations when I'm covering subject matter not shrouded in smoke and mirrors. So that's how I intend to proceed.

There's no better way to start (and continue) in 2014 than with Pandora (P). Once treated like a cartoon by an unwitting financial media, it's a company that now commands, relatively speaking, a considerable level of respect. I like to think my work, as well as the work of Wall Street analysts such as Richard Tullo at Albert Fried and a handful of fellow media members, played a small role in the creation of this new level of understanding. 

While I can't speak for others, I don't consider it my job to make you like Pandora or believe in the company and its personalization and discovery platforms as much as I do. Rather, I'm here to do the work. To get as deep behind the scenes as I can. To build the relationships. And, from there, relay information others fail to provide so you can draw your own conclusions.  

Here's a preview of what lies ahead in this exclusive series on Pandora, followed by some context and the first couple video installments on Page Two. 

Ever since Pandora went public in June 2011, I have established relationships with folks from every corner of the organization. From Pandora's co-founder Tim Westergren to several executives and dozens of key employees. While I have been largely bullish on the company and stock, I'm proud to observe that I have been not only objective on, but critical of Pandora at (or close to) the appropriate times.

See Pandora Must Do Better Now for an example of where I have pushed the company.

My work over the last 2.5 years has helped me obtain more access to the people and technology at Pandora than most, from the tech to the financial to the music media. In fact, in December 2013, I received the deepest behind the scenes look at Pandora's Music Genome Project (MGP) ever provided to somebody from the outside:

In that tease video, I'm combing through the way the MGP serves up songs, track by track, in my personal Pandora account with the company's VP of Playlists and Chief Scientist Eric Bieschke. You can learn more about Bieschke and see what turned out be a surface scratch look at the MGP in this article from October 2013.

In the present article (on the next page) and several others that will follow here at TheStreet, we take things several steps further.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,054.67 +0.96 0.01%
S&P 500 2,091.47 +2.70 0.13%
NASDAQ 4,805.14 -1.7190 -0.04%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs